Scarica l'app Stockscreener
4.15
1.19%
-0.05
Precedente Chiudi:
$4.20
Aprire:
$4.23
Volume 24 ore:
639.69K
Relative Volume:
0.43
Capitalizzazione di mercato:
$412.21M
Reddito:
$58.36M
Utile/perdita netta:
$-25.72M
Rapporto P/E:
-11.40
EPS:
-0.3641
Flusso di cassa netto:
$-24.91M
1 W Prestazione:
-1.19%
1M Prestazione:
+27.69%
6M Prestazione:
+34.30%
1 anno Prestazione:
+20.29%
Intervallo 1D:
$4.09
$4.23
Intervallo di 1 settimana:
$3.955
$4.3693
Portata 52W:
$2.12
$5.80
Aquestive Therapeutics Inc Stock (AQST) Company Profile
Nome
Aquestive Therapeutics Inc
Settore
Telefono
908-941-1900
Indirizzo
30 TECHNOLOGY DRIVE, WARREN, NJ
Confronta AQST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
4.15 | 417.18M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
152.12 | 68.04B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.48 | 46.30B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.88 | 44.25B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.54 | 18.73B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
304.50 | 13.82B | 2.99B | 1.21B | 1.13B | 25.06 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-05-10 | Iniziato | Leerink Partners | Outperform |
| 2024-04-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-04-22 | Iniziato | H.C. Wainwright | Buy |
| 2019-01-03 | Iniziato | Lake Street | Buy |
| 2018-08-20 | Iniziato | JMP Securities | Mkt Outperform |
| 2018-08-20 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Is Aquestive Therapeutics Inc. a good long term investmentExceptional stock performance - PrintWeekIndia
Why Aquestive Therapeutics Inc. stock is on top investor watchlistsFree Bull & Bear Market Updates - jammulinksnews.com
Should I buy Aquestive Therapeutics Inc. stock before earningsRapidly growing investment returns - jammulinksnews.com
Aquestive Therapeutics Inc. Stock Analysis and ForecastBreakthrough investment results - PrintWeekIndia
What analysts say about Aquestive Therapeutics Inc. stock outlookRobust financial gains - jammulinksnews.com
What drives Aquestive Therapeutics Inc. stock priceFree Capital Allocation Plans - Autocar Professional
What analysts say about Aquestive Therapeutics Inc. stockAccelerated profit realization - jammulinksnews.com
Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer - GlobeNewswire
EpiPen Veteran to Lead Aquestive's Revolutionary Oral Epinephrine Launch as New Chief Commercial Officer - Stock Titan
After Leaping 29% Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Are Not Flying Under The Radar - simplywall.st
Aquestive's Anaphylm to be reviewed by Health Canada - MSN
When is the best time to buy Aquestive Therapeutics Inc. stockAlpha Stock Ideas - Newser
Will Aquestive Therapeutics Inc. stock benefit from AI tech trendsFree Professional Portfolio Management - Newser
Why Aquestive Therapeutics Inc. stock attracts strong analyst attentionSteady Income Ideas - beatles.ru
Cantor Equity Partners I, Inc. shares rise 2.24% premarket after Aquestive Therapeutics' positive drug submission meeting with Health Canada. - AInvest
11,303 Shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST) Acquired by Cambridge Investment Research Advisors Inc. - Defense World
Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film - GlobeNewswire
What makes Aquestive Therapeutics Inc. stock price move sharplyFree High-Profit Stock Picks - Newser
Aquestive's Anaphylm to be reviewed by Health Canada (AQST) - Seeking Alpha
Aquestive schedules regulatory meetings for epinephrine film in Canada, EU - Investing.com Canada
How Aquestive Therapeutics Inc. stock performs during market volatilityDaily Stock Radar - Newser
Aquestive Therapeutics Inc Azioni (AQST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.82%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):